Omega 3

Omega 3 project

Omega 3 Production Project through Liquid Fermentation

1. Introduction to Omega 3

Omega-3 is an essential fatty acid with multiple health benefits, widely used in nutritional supplements, cosmetics, and pharmaceuticals. It plays a crucial role in brain function, cardiovascular health, and cellular regeneration. The global demand for Omega-3 has significantly increased due to the rising preference for natural and biotechnological products, positioning it as a key ingredient in various industries.

2. Advantages of Fermentation-Based Production

Our approach focuses on Omega-3 production through controlled liquid fermentation using the microorganism Yarrowia lipolytica, known for its ability to produce high-value fatty acids.

  • High purity and sustainability: Biotechnological production ensures Omega-3 extraction without relying on marine sources, preventing ocean overexploitation and delivering a cleaner, contaminant-free product.
  • Scalability: The fermentation process adapts to different production capacities, ensuring long-term business profitability as demand increases.
  • High efficiency: Yarrowia lipolytica fermentation presents a high substrate-to-Omega-3 conversion rate, reducing production costs and time.
3. Development Plan
  • Phase I (R&D): Validation of Pichia pastoris strains, pilot bioreactor trials, and evaluation of cultivation parameters.
  • Phase II (Pilot Scaling and Certification Implementation): Adjustment of production capacity, adoption of international standards (GMP, ISO), and acquisition of relevant health certifications.
  • Phase III (Industrial Production and Expansion): Consolidation of production capacity, formalization of partnerships with international distributors, and brand positioning in global markets.
Omega 3 - investors - banner
4. Development and Scaling Plan

Phase I:  Research and Development (R&D)

  • Strain optimization in pilot bioreactors.
  • Fermentation parameter studies (pH, temperature, substrates).
  • Omega-3 quality evaluation to meet international industry standards

Phase II: Pilot Plant and Certifications

  • Process upscaling to a mid-capacity pilot plant.
  • Implementation of quality regulations (GMP, ISO)and registration with national and international regulatory entities.

Phase III:  Industrial Production and Commercialization

  • Increasing production capacity and optimizing costs.
  • Developing alliances with global distributors and pharmaceutical/cosmetic laboratories.
  • Expanding to high-value markets such as the U.S., Europe, and Asia.
5. Market Potential and Profitability
  • Sustained market growth: The global demand for Omega-3 continues to expand due to its health applications.
  • High profitability: Biotechnological production ensures operational efficiency and attractive profit margins.
  • Diversification opportunities: The infrastructure and expertise developed in this project can be applied to other bioproducts, expanding the business potential.
6. Investment Opportunity

We seek strategic investors, particularly in Europe, Asia and the United States, who want to participate in an innovative project with strong growth and profitability potential.

By joining this initiative, investors will benefit from:

  • A scalable and sustainable business model.
  • Participation in an expanding industry. 
  • Cutting-edge biotechnology-driven innovation.

Contact information

Links

Information

All rights reserved Europa Biotechnology